| Youm YH et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015 Mar;21(3):263-9 | Lire le résumé |
| Coll RC et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015 Mar;21(3):248-55 | Lire le résumé |
| Schultze JL. Teaching 'big data' analysis to young immunologists. Nat Immunol. 2015 Aug 19;16(9):902-5 | Lire le résumé |
| Li YR et al. Meta-analysis of shared genetic : architecture across ten pediatric autoimmune diseases. Nat Med. 2015 Aug 24 | Lire le résumé |
| Hung T et al. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science. 2015 Sep 17 | Lire le résumé |
| Marta Rusmini et al. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. Ann Rheum Dis. 2015 Sep 17 | Lire le résumé |
| Wraith D. Autoimmunity: Antigen-specific immunotherapy. Nature. 17 févr 2016 | Lire le résumé |
| Clemente-Casares X et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 17 févr 2016 | Lire le résumé |
| Oftedal BE et al. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 2015 June 16;42(6):1185-96. | Lire le résumé |
| Meuwissen MEC et al. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J Exp Med. 20 juin 2016 | Lire le résumé |
| Frémond M-L et al. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. J Allergy Clin Immunol. 20 août 2016 | Lire le résumé |
